Previous Next

2024-02-29

Antihypertensive treatment and breast cancer

Pharmacology and Toxicology

Available data on the links between antihypertensive drugs and breast cancer risk remain inconsistent. In this study, researchers used two-sample Mendelian randomization analyses to assess relationships between genetically predicted traits of high blood pressure and breast cancer risk. Overall breast cancer risk was associated with the expression of only one gene considered, the SLC12A2 gene. Decreased expression of this gene was associated with a significant reduction in systolic blood pressure, but with an increased risk of breast cancer.

Source(s) :
Guoqiao Zheng et al. Antihypertensive drug targets and breast cancer risk: a two-sample Mendelian randomization study. Eur J Epidemiol. 2024 Feb 24. ;

Last press reviews


COVID-19 and coagulation parameters: a link to mortality?

The COVID-19 pandemic, caused by SARS-CoV-2, has led to millions of deaths...

Resistance training and Multiple Sclerosis: a solution to improve function and quality of life?

Multiple sclerosis (MS) is a chronic autoimmune disease of the central ner...

Endometriosis: the Impact of hormones, sexual practice, and surgical treatments

Endometriosis is a chronic inflammatory disease modulated by estrogen leve...